Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease
Author(s) -
Amanda Cohn,
Jessica R. MacNeil,
Lee H. Harrison,
Cynthia Hatcher,
Jordan M. Theodore,
Mark A. Schmidt,
Tracy Pondo,
Kathryn E. Arnold,
Jan Baumbach,
Nancy M. Bennett,
Allen S. Craig,
Monica M. Farley,
Ken Gershman,
Susan Petit,
Ruth Lynfield,
Arthur Reingold,
William Schaffner,
Kathleen A. Shutt,
Elizabeth R. Zell,
Leonard W. Mayer,
Thomas A. Clark,
David S. Stephens,
Nancy E. Messonnier
Publication year - 2009
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/649209
Subject(s) - neisseria meningitidis , meningococcal disease , medicine , incidence (geometry) , meningococcal vaccine , epidemiology , population , conjugate vaccine , vaccination , confidence interval , pediatrics , immunology , immunization , environmental health , antigen , bacteria , biology , genetics , physics , optics
In January 2005, a quadrivalent (serogroups A, C , Y, and W-135) meningococcal conjugate vaccine was licensed for use in adolescents. This report describes the epidemiologic features of meningococcal disease in the United States from January 1998 through December 2007, before and during implementation of adolescent quadrivalent meningococcal conjugate vaccination.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom